Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matthew P. Crump is active.

Publication


Featured researches published by Matthew P. Crump.


The EMBO Journal | 1997

Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1

Matthew P. Crump; Jiang Hong Gong; Pius Loetscher; Krishna Rajarathnam; Ali Amara; Fernando Arenzana-Seisdedos; Jean Louis Virelizier; Marco Baggiolini; Brian D. Sykes; Ian Clark-Lewis

The three‐dimensional structure of stromal cell‐derived factor‐1 (SDF‐1) was determined by NMR spectroscopy. SDF‐1 is a monomer with a disordered N‐terminal region (residues 1–8), and differs from other chemokines in the packing of the hydrophobic core and surface charge distribution. Results with analogs showed that the N‐terminal eight residues formed an important receptor binding site; however, only Lys‐1 and Pro‐2 were directly involved in receptor activation. Modification to Lys‐1 and/or Pro‐2 resulted in loss of activity, but generated potent SDF‐1 antagonists. Residues 12–17 of the loop region, which we term the RFFESH motif, unlike the N‐terminal region, were well defined in the SDF‐1 structure. The RFFESH formed a receptor binding site, which we propose to be an important initial docking site of SDF‐1 with its receptor. The ability of the SDF‐1 analogs to block HIV‐1 entry via CXCR4, which is a HIV‐1 coreceptor for the virus in addition to being the receptor for SDF‐1, correlated with their affinity for CXCR4. Activation of the receptor is not required for HIV‐1 inhibition.


Nature Chemistry | 2012

A simple and accessible synthetic lectin for glucose recognition and sensing

Chenfeng Ke; Harry Destecroix; Matthew P. Crump; Anthony P. Davis

Binding carbohydrates from water is a difficult task, even for the natural carbohydrate-binding proteins known as lectins. The design of synthetic lectin mimics is correspondingly challenging, especially if good selectivities are required. In previous work we showed that success is possible, but only for complex polycyclic architectures that require lengthy and low-yielding syntheses; for example, one glucose-selective system was made in 21 steps and only 0.1% overall yield. Here we report the discovery of a simple monocyclic host that matches the earlier designs, but is far more accessible as it is prepared in just five steps and 23% overall yield. The new synthetic lectin binds glucose with excellent selectivity versus other common monosaccharides (for example, ~50:1 versus galactose) and sufficient affinity for glucose sensing at the concentrations found in blood. It also features a built-in signalling system in the form of strong and guest-dependent fluorescence emission. The effectiveness and simplicity of this molecule suggests the potential for development into a new methodology for practical glucose monitoring.


ChemBioChem | 2008

Authentic Heterologous Expression of the Tenellin Iterative Polyketide Synthase Nonribosomal Peptide Synthetase Requires Coexpression with an Enoyl Reductase

Laura M. Halo; James W. Marshall; Ahmed A. Yakasai; Zhongshu Song; Craig P. Butts; Matthew P. Crump; Mary N. Heneghan; Andy M. Bailey; Thomas J. Simpson; Colin M. Lazarus; Russell J. Cox

The tenS gene encoding tenellin synthetase (TENS), a 4239‐residue polyketide synthase nonribosomal‐peptide synthetase (PKS‐NRPS) from Beauveria bassiana, was expressed in Aspergillus oryzae M‐2‐3. This led to the production of three new compounds, identified as acyl tetramic acids, and numerous minor metabolites. Consideration of the structures of these compounds indicates that the putative C‐terminal thiolester reductase (R) domain does not act as a reductase, but appears to act as a Dieckmann cyclase (DKC). Expression of tenS in the absence of a trans‐acting ER component encoded by orf3 led to errors in assembly of the polyketide component, giving clues to the mode of programming of highly reducing fungal PKS. Coexpression of tenS with orf3 from the linked gene cluster led to the production of a correctly elaborated polyketide. The NRPS adenylation domain possibly shows the first identified fungal signature sequences for tyrosine selectivity.


Angewandte Chemie | 2009

A Synthetic Lectin for O-Linked β-N-Acetylglucosamine†

Yann Ferrand; Emmanuel Klein; Nicholas P. Barwell; Matthew P. Crump; Jesús Jiménez-Barbero; Cristina Vicent; Geert-Jan Boons; Sampat Ingale; Anthony P. Davis

Changing employment: Receptor 1 binds beta-N-acetylglucosaminyl (beta-GlcNAc) up to 100 times more strongly than it does glucose. This synthetic lectin shows affinities similar to wheat germ agglutinin (WGA), a natural lectin used to bind GlcNAc. Remarkably, 1 is more selective than WGA. It favors especially the glycoside unit in glycopeptide 2, a model of the serine-O-GlcNAc posttranslational protein modification.


Journal of Biological Chemistry | 2001

Structure of a pilin monomer from Pseudomonas aeruginosa: implications for the assembly of pili.

David W. Keizer; Carolyn M. Slupsky; M Kalisiak; A.P Campbell; Matthew P. Crump; P.A Sastry; B Hazes; R.T Irvin; B.D. Sykes

Type IV pilin monomers assemble to form fibers called pili that are required for a variety of bacterial functions. Pilin monomers oligomerize due to the interaction of part of their hydrophobic N-terminal α-helix. Engineering of a truncated pilin fromPseudomonas aeruginosa strain K122-4, where the first 28 residues are removed from the N terminus, yields a soluble, monomeric protein. This truncated pilin is shown to bind to its receptor and to decrease morbidity and mortality in mice upon administration 15 min before challenge with a heterologous strain of Pseudomonas. The structure of this truncated pilin reveals an α-helix at the N terminus that lies across a 4-stranded antiparallel β-sheet. A model for a pilus is proposed that takes into account both electrostatic and hydrophobic interactions of pilin subunits as well as previously published x-ray fiber diffraction data. Our model indicates that DNA or RNA cannot pass through the center of the pilus, however, the possibility exists for small organic molecules to pass through indicating a potential mechanism for signal transduction.


Journal of Biological Chemistry | 1998

Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation.

Matthew P. Crump; Krishna Rajarathnam; Key Sun Kim; Ian Clark-Lewis; Brian D. Sykes

The solution structure of the CCR3-specific chemokine, eotaxin, has been determined by NMR spectroscopy. The quaternary structure of eotaxin was investigated by ultracentrifugation and NMR, and it was found to be in equilibrium between monomer and dimer under a wide range of conditions. At pH ≤ 5 and low ionic strength, eotaxin was found to be predominantly a monomer. The three-dimensional structure of the eotaxin monomer solved at pH 5.0 revealed that it has a typical chemokine fold, which includes a 3-stranded β-sheet and an overlying α-helix. Except for the N-terminal residues (residues 1–8), the core of the protein is well defined. The eotaxin structure is compared with the chemokines regulated upon activation, normal T-cell expressed and secreted (RANTES) and monocyte chemoattractant protein-1 (MCP-1); eotaxin binds only CC chemokine receptor CCR3, whereas RANTES binds many receptors including CCR3, and MCP-1 binds a distinct receptor, CCR2. The RMSD of the eotaxin ensemble of structures with the RANTES average minimized monomeric subunit is 5.52 ± 0.87 Å over all backbone atoms and 1.14 ± 0.09 Å over backbone atoms of residues 11–28 and 34–65. The most important difference between the structures is in the N-terminal residues that are unstructured in eotaxin but structured in RANTES and MCP-1. Several residues in the loop region of RANTES show similar packing in eotaxin (residues 11–17). As the N-terminal and loop regions have been shown to be critical for receptor binding and signaling, this structure will be useful for determining the basis for CCR3 selectivity of the eotaxin.


Natural Product Reports | 2012

The structural role of the carrier protein - active controller or passive carrier

John Crosby; Matthew P. Crump

Common to all FASs, PKSs and NRPSs is a remarkable component, the acyl or peptidyl carrier protein (A/PCP). These take the form of small individual proteins in type II systems or discrete folded domains in the multi-domain type I systems and are characterized by a fold consisting of three major α-helices and between 60-100 amino acids. This protein is central to these biosynthetic systems and it must bind and transport a wide variety of functionalized ligands as well as mediate numerous protein-protein interactions, all of which contribute to efficient enzyme turnover. This review covers the structural and biochemical characterization of carrier proteins, as well as assessing their interactions with different ligands, and other synthase components. Finally, their role as an emerging tool in biotechnology is discussed.


ChemBioChem | 2008

Photocontrollable Peptide-Based Switches Target the Anti-Apoptotic Protein Bcl-xL

Sabine Kneissl; Edric Joel Loveridge; Christopher Williams; Matthew P. Crump; Rudolf Konrad Allemann

Photocontrol of Bcl‐xL binding affinity has been achieved by using short BH3 domain peptides for Bak72–87 and Bid91–111 alkylated with an azobenzene crosslinker through two cysteine residues with different sequence spacings. The power to control the conformation of the crosslinker and hence peptide structure was demonstrated by CD and UV/Vis spectroscopy. The binding affinity of the alkylated peptides with Bcl‐xL was determined in their dark‐adapted and irradiated states by fluorescence anisotropy measurements, and use of different cysteine spacings allowed either activation or deactivation of the binding activities of these peptide‐based switches by application of light pulses. Helix‐stabilized peptides exhibited high Bcl‐xL binding affinity with dissociation constants of 42±9, 21±1, and 55±4 nM for Bak


Journal of Biological Chemistry | 2008

A Mammalian Type I Fatty Acid Synthase Acyl Carrier Protein Domain Does Not Sequester Acyl Chains

Eliza Płoskoń; Christopher J. Arthur; Simon Evans; Christopher Williams; John Crosby; Thomas J. Simpson; Matthew P. Crump

{{{i+ 7\atop 72-87}}}


Journal of Medicinal Chemistry | 2012

Automated protein-ligand interaction screening by mass spectrometry.

Hannah J. Maple; Rachel A. Garlish; Laura Rigau-Roca; John B. Porter; Ian Whitcombe; Christine E. Prosser; Jeffrey D. Kennedy; Alistair J. Henry; Richard Taylor; Matthew P. Crump; John Crosby

, Bak

Collaboration


Dive into the Matthew P. Crump's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Brian D. Sykes

Université de Sherbrooke

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge